EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18 | +350.0% | 57 | +1040.0% | 0.00% | – |
| Q2 2023 | $4 | -100.0% | 5 | -100.0% | 0.00% | – |
| Q1 2023 | $12,197 | -34.8% | 13,597 | -14.2% | 0.00% | – |
| Q4 2022 | $18,703 | -49.5% | 15,850 | +223.6% | 0.00% | – |
| Q3 2022 | $37,000 | -11.9% | 4,898 | -25.7% | 0.00% | – |
| Q2 2022 | $42,000 | -61.8% | 6,593 | -50.1% | 0.00% | – |
| Q1 2022 | $110,000 | +61.8% | 13,209 | +0.9% | 0.00% | – |
| Q4 2021 | $68,000 | +172.0% | 13,086 | +245.6% | 0.00% | – |
| Q3 2021 | $25,000 | +25.0% | 3,786 | +62.7% | 0.00% | – |
| Q2 2021 | $20,000 | -9.1% | 2,327 | -4.7% | 0.00% | – |
| Q1 2021 | $22,000 | -98.0% | 2,443 | -97.2% | 0.00% | – |
| Q4 2020 | $1,083,000 | +67.1% | 88,087 | +10.6% | 0.00% | – |
| Q3 2020 | $648,000 | -24.8% | 79,669 | -11.3% | 0.00% | – |
| Q2 2020 | $862,000 | +85.0% | 89,785 | +31.1% | 0.00% | – |
| Q1 2020 | $466,000 | +14.5% | 68,481 | +150.5% | 0.00% | – |
| Q4 2019 | $407,000 | +132.6% | 27,341 | +59.8% | 0.00% | – |
| Q3 2019 | $175,000 | +3400.0% | 17,111 | +3288.3% | 0.00% | – |
| Q2 2019 | $5,000 | -28.6% | 505 | 0.0% | 0.00% | – |
| Q1 2019 | $7,000 | -68.2% | 505 | -76.5% | 0.00% | – |
| Q4 2018 | $22,000 | +100.0% | 2,146 | +134.5% | 0.00% | – |
| Q3 2018 | $11,000 | +83.3% | 915 | +81.2% | 0.00% | – |
| Q2 2018 | $6,000 | -62.5% | 505 | -68.5% | 0.00% | – |
| Q1 2018 | $16,000 | -23.8% | 1,601 | +5.4% | 0.00% | – |
| Q4 2017 | $21,000 | – | 1,519 | +7894.7% | 0.00% | – |
| Q3 2017 | $0 | – | 19 | -62.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 50 | -96.8% | 0.00% | – |
| Q1 2017 | $18,000 | +80.0% | 1,576 | +87.0% | 0.00% | – |
| Q4 2016 | $10,000 | 0.0% | 843 | +16.8% | 0.00% | – |
| Q3 2016 | $10,000 | – | 722 | +14340.0% | 0.00% | – |
| Q2 2016 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 540,000 | $4,482,000 | 4.68% |
| Knoll Capital Management, LLC | 694,232 | $5,762,000 | 3.62% |
| Telemetry Investments, L.L.C. | 213,000 | $1,768,000 | 2.79% |
| ACT CAPITAL MANAGEMENT, LLC | 250,000 | $2,075,000 | 2.20% |
| VR Adviser, LLC | 1,469,767 | $12,199,000 | 1.98% |
| INTERWEST VENTURE MANAGEMENT CO | 560,990 | $4,656,000 | 1.78% |
| 683 Capital Management, LLC | 3,375,000 | $28,013,000 | 1.50% |
| Trellus Management Company, LLC | 300,000 | $2,490,000 | 1.45% |
| Altium Capital Management LP | 440,000 | $3,652,000 | 1.22% |
| CAXTON CORP | 116,884 | $970,000 | 1.21% |